Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3689b (MIR3689B) is a small, non-coding RNA gene in humans that produces a mature microRNA molecule after a two-step processing pathway involving Drosha and Dicer enzymes. MicroRNAs are 20–24 nucleotide RNAs that regulate gene expression by targeting messenger RNAs for translational inhibition or destabilization via the Argonaute (RISC) complex. These molecules play broad roles in numerous cellular processes by modulating gene expression, but there is no current evidence to indicate that MIR3689B functions as a disease gene, drug target, or established clinical biomarker. MIR3689B is classified as a non-coding RNA within the microRNA (miRNA) family and is not described as a receptor, enzyme, transporter, or other classical drug target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3689b (MIR3689B).